GNLX - Genelux Corp. Market Cap to Sales Volume

Corporate company logo of Genelux Corporation (GNLX)

Genelux Corporation relies on transparent management with deep oncology expertise and close partnerships with external research centers. This P/S chart confirms the market valuation of these processes, where 8720.40 indicates the current multiple level. The company focuses on creating modified viruses for the targeted destruction of tumors, establishing a new standard for cancer therapy.

Genelux Corporation (GNLX) - Price-to-Revenue Ratio from 04/28/2023 to 11/17/2026

Metric breakdowns and analytics for Genelux Corp. (GNLX)

- stock value and consensus price forecast:
Fundamental company analysis:GNLX, Genelux Corp
Finished products of Genelux

The price-to-sales ratio compares the market value of Genelux Corporation (GNLX) to its generated sales volume, allowing investors to assess the premium paid for every dollar of revenue. For a biotech startup without commercial products, this price-to-sales ratio reflects speculative market expectations regarding future clinical trial successes rather than current efficiency, given the total absence of internal cash flow.